-+ 0.00%
-+ 0.00%
-+ 0.00%

DiaMedica Therapeutics Enrolls 200th Patient In ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial

Benzinga·10/22/2026 12:03:24
Listen to the news
  • Independent Data Safety Monitoring Board to Conduct a Pre-Specified Interim Analysis to Assess Need for Sample Size Re-Estimation
  • Interim Analysis Results Expected in Q1 2027